The FDA just changed the rules on peptides effective April 15, 2026. BPC 157, GHK Cu, MOTS C, and TB 500 have been removed from the Category 2 restricted compounding list. Here is what FDA Peptide Ban Lifted: Legit Compounding Pharmacies Now Regulate Julian Becerra posted on the topic LinkedIn FDA May Reverse Ban on 14 PeptidesWhat It Means for Your Beauty Routine Allure Regulatory Alert: FDA's April 2026 Update on BPC 157 and GHK Cu Holt Law